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Abstract Selected Phosphoinositide-specific Phospholipase
C (PI-PLC) enzymes occupy the convergence point of the
broad range of pathways that promote Rho and Ras GTPase
mediated signalling, which also regulate the activation of
ezrin, a member of the ezrin-radixin-moesin (ERM) proteins
family involved in the metastatic osteosarcoma spread. Previ-
ous studies described that in distinct human osteosarcoma cell
lines ezrin networks the PI-PLC with complex interplay con-
trolling the expression of the PLC genes, which codify for PI-
PLC enzymes. In the present study, we analyzed the expres-
sion and the sub-cellular distribution of RhoA and Rac1 re-
spectively after ezrin silencing and after PI-PLC ε silencing, in
order to investigate whether ezrin-RhoGTPAses signalling
might involve one or more specific PI-PLC isoforms in cul-
tured 143B and Hs888 human osteosarcoma cell lines. In the
present experiments, both ezrin and PLCE gene silencing had
different effects upon RhoA and Rac1 expression and sub-
cellular localization. Displacements of Ezrin and of RhoA
localization were observed, probably playing functional roles.
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Introduction
Osteosarcoma, the most common primary bone tumour in
childhood and adolescence, comprises of different clinical,
radiological, and histological entities. Usually, metastatic os-
teosarcoma spread confers worse prognosis to the clinical out-
come of patients presenting with osteosarcoma (Mirabello
et al. 2009; Gatta et al. 2005).
Ezrin, the first characterized member of the ezrin-radixin-
moesin (ERM) proteins family, acts as a general cross-linker
of actin to the plasma membrane (Khanna et al. 2004; Ferrari
et al. 2008), and was suggested to be involved in the metasta-
sizing process (Khanna et al. 2004).
The Band 4.1, Ezrin, radixin, moesin homology (FERM)
domain (PBD ID:1GC6) of ERM proteins is involved in the
recognition of Phosphatydil inositol (Ferrari et al. 2008; Fievet
et al. 2007) bisphosphate (PIP2), a crucial molecule belonging
to the PI system (Fievet et al. 2004, 2007). The activation of
ERM proteins invariably requires PIP2 local accumulation
(Hartwig et al. 1995; Tolias et al. 2000; Honda et al. 1999).
Two putative binding sites were identified, and PIP2 binding
was demonstrated to be essential in guiding ezrin to cell sur-
face locations (Barret et al. 2000). The reduction of PIP2
levels induces ERM protein dissociation from the membrane
(Hao et al. 2009). The levels of plasma membrane PIP2 are
regulated bymeans of the Phosphoinositide-specific Phospho-
lipase C (PI-PLC) family (Berridge and Dupont 1994;
Divecha and Irvine 1995; Hisatsune et al. 2005; Rhee 2001;
Bunney and Katan 2011; Fukami et al. 2010), complex, mod-
ular, multi-domain enzymes which cover a wide spectrum of
regulatory interactions, including direct binding to Ras
GTPases (Rhee et al. 1991; Berridge 1993; De Smedt and
Parys 1995; Nishizuka 1995; Irvine 2003; Suh et al. 2008).
In mammals, PI-PLC enzymes were divided into six sub-
families on the basis of amino acid sequence, domain structure
and mechanism of recruitment: β(1−4), γ(1, 2), δ(1, 3 and 4),
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ε(1), ζ(1), and η(1 and 2) (Suh et al. 2008). The presence of
distinct regulatory domains renders each sub-family suscepti-
ble to different mechanisms of activation (Suh et al. 2008).
Previous studies placed selected PI-PLC enzymes at the con-
vergence point of pathways involved in the Ras GTPase me-
diated signalling (Hao et al. 2009), which also regulates ezrin
activation.
PI-PLC ε isoform is a direct effector of the members of the
Rho family (RhoGTPases), belonging to the Ras superfamily
(Ridley 2001). PI-PLC ε can be directly and concomitantly
activated by both RhoA and individual Ras GTPases resulting
in diverse upstream control of signalling cascades down-
stream of PI-PLC ε by a variety of hormones, neurotransmit-
ters, growth factors and other molecules (Suh et al. 2008; Lo
Vasco et al. 2014a).
PI-PLC β subfamily enzymes can be activated by the Rho-
GTPase family member Rac, comprising Rac1, Rac2, and
Rac3, which interacts with the pleckstrin homology (PH) do-
main of PI-PLC enzymes (Hao et al. 2009). Rac1 was sug-
gested to be involved in in actin polymerization ), cell prolif-
eration, and in the regulation of the cell cycle (Joneson and
Bar-Sagi 1997; Steffen et al. 2004; Moore et al. 1997;
Juncadella et al. 2013). Moreover, Rac1 was demonstrated
to induce cell transformation in vitro (Benitah et al. 2004)
and malignant transformation (Gómez del Pulgar et al. 2005).
Therefore, both ezrin and some PI-PLC isoforms are regu-
lated by Ras signalling and can bind PIP2 (Hao et al. 2009;
Snyder et al. 2003). In our previous studies, the panel of ex-
pression of PI-PLC ε differed in distinct osteosarcoma cell
lines, probably due to the different origin of the cells (Lo
Vasco et al. 2013a). The transcription of PLCE gene was af-
fected by Ezrin silencing (Lo Vasco et al. 2014b) and tran-
scription of Ezrin, as well as of selected PI-PLC enzymes, was
affected by PI-PLC ε silencing (Lo Vasco et al. 2014c). The
levels of networking in the recruitment remained to be
elucidated.
In the present study, we analyzed the expression and the
sub-cellular distribution of RhoA and Rac1 in 143B and
Hs888 human osteosarcoma cell lines after ezrin (Vil2 gene,
OMIM *123900) silencing or after PI-PLC ε silencing, in
order to investigate whether ezrin-RasGTPases signalling
might involve one or more PI-PLC enzyme. Our aim was to
investigate the hypothesis that ezrin-RhoGTPase-PLC path-
way might exist and/or that different localization of
RhoGTPases might occur after ezrin reduction.
Materials and methods
Cell cultures
Two human osteosarcoma cell lines, 143B and Hs888, were
obtained from the American Type Culture Collection (ATCC,
Rockville, MD, USA). Cells were cultured in Dulbecco’s
modified Eagle’s medium (DMEM) supplemented with 10–
15 % foetal bovine serum (FBS), 1 mM sodium pyruvate,
100 U/mL of penicillin, and 100 mg/mL of streptomycin, at
37 °C and 5 % CO2 according to producer’s recommenda-
tions. Cells were grown at 37 °C in a humidified atmosphere
containing 5 % CO2 in a Forma Scientific incubator (USA).
Confluent monolayer of cells was rinsed with phosphate-
buffered saline (PBS) and detached using 0.25 % Trypsin/
EDTA (disodium ethylene diaminetetraacetate). Cells were
counted using a Neubauer haemocytometer (Weber Scientific
International Ltd., Middlesex, UK), and stored at −20 °C until
use.
Cells transfection for Ezrin and PLCE silencing
Cultures of 143B and Hs888 cells were transiently transfected
with Vil2 or PLCE silencing RNA using METAFECTENE
SI+ (Biontex Laboratories GmbH, Munich, Germany).
siRNA sequences respectively targeting Vil2 or PLCE and
negative control siRNA were designed and synthesized by
Invitrogen (Life Technologies, Foster City, CA, USA). The
siRNAwas designed according toVil2 andPLCE complemen-
tary DNA (cDNA) sequence (Vil2 Gene ID: 7430; PLCE
Gene ID: 51196). Briefly, 2.2 ml cell suspension were pre-
pared in complete cell culture medium with a concentration
of 1,5·10^5 cells/ml of 143B cells and 3·10^5 cells/ml of
Hs888. Cells were seeded in 6-well plates, transfected with a
mixture of 150 μl of 1× SI+ buffer with previously incubated
with 72 μl of METAFECTENE® SI+ and 540 pMol of RNA
stock solution according to the manufacturer’s instructions.
Then cells were incubated at 37 °C in CO2–containing atmo-
sphere for 72 h. Functional siRNA was measured by reverse
transcription–polymerase chain reaction (RT-PCR) and west-
ern blot analysis resepctively 24, and 48 after tranfection.
Contemporarily, a growth curve was designed.
RNA extraction
Total RNA was extracted with SV Total RNA Isolation Sys-
tem (Promega, Madison, WI, USA) according to the manu-
facturer’s instructions. The cells were transferred to a
microcentrifuge tube containing 175 μL of SV RNA Lysis
Buffer and passed through a 20-gauge needle to shear the
genomic DNA. 350 μL of SV Dilution Buffer was added in
a heating block at 70 °C for 3 min. The sample was centri-
fuged for 10 min at 14,000×g. The lysate solution was trans-
ferred to a new microcentrifuge tube, 200 μL of 95 % ethanol
were added, and the mixture was transferred to a spin column
assembly, and centrifuged at 14,000×g for one minute. The
liquid was discarded from the collection tube, 600 μL of SV
RNAWash Solution was added to the column, centrifuged at
14,000×g for one minute, and the collection tube was emptied.
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A DNase incubation mixture was prepared per sample by
combining 40 μL Yellow Core Buffer (Promega), 5 μL
0.09 M MnCl2 and 5 μL of DNase I enzyme. The DNase
incubation mixture was directly added, incubated for 15 min
at room temperature, then 200 μL of SV DNase Stop Solution
was added to the spin basket, and centrifuged at 14,000×g for
1 min. 600 μL of SV RNA Wash Solution was added and
centrifuged at 14,000×g for 1 min. The collection tube was
emptied, 250 μL of SV RNAWash Solution was added, and
centrifuged at 14,000×g for 2 min. The spin basket was trans-
ferred to an elution tube, 100 μL of Nuclease-Free Water was
added to the membrane and centrifuged at 14,000×g for 1 min.
RNAwas eluted into a sterile collection tube with RNase-free
water. The concentration and quality of the RNA obtained was
monitored using a NanoDrop ND-1000 Spectrophotometer
(Thermo Fisher Scientific, Inc. USA).
RT-PCR
RNA was reverse-transcribed into cDNA using High-
Capacity cDNA Reverse Transcription Kit (Life Technolo-
gies, Foster City, CA, USA). Briefly, 2 μg RNA were incu-
bated with the master mix (2 μl of 10 × Reverse Transcription
Buffer, 0.8 μl of 25 × dNTPs (100 mM), 2 μl of 10× random
primers, 1 μl of MultiScribeTM Reverse Transcriptase (50 U/
μl) and 3.2 μl of DNase-free water). 10μl of diluted RNAwas
then added to 20 μl final volume. The RNA mix was then
amplified for 10 min at 25 °C, 120 min at 37 °C and 5 min
at 85 °C in a Gene Amp® PCR System 9700 (Applied
Biosystems) thermocycler.
The primer pairs (Bio Basic Inc, Amherst, New York,
USA) for PI-PLC isoforms are listed in Table 1. To amplify
glyceraldehyde 3 phosphate dehydrogenase (GAPDH) (Bio
Basic Inc, Amherst, New York, USA) as a positive control,
the following primer pair was used: forward 5′-CGAGATCC
CTCCAAAATCAA-3′ reverse 5′-GTCTTCTGGGTGGCAG
TGAT-3′. The following primers were used to amplify RhoA:
forward, 5′-TGAAAACTATGTGGCGGATATCG; reverse,
5′-TCTGCTTCTTCAGGTTTAACCGG and Rac1: forward
5’-ATG CAG GCC ATC AAG TGT GTG GTG and reverse
3'-TTA CAA CAG CAG GCA TTT TCT CTT CC). The
specificity of the primers was verified by searching in the
NCBI database for possible homology to cDNAs of unrelated
proteins. RNA samples were also amplified by PCR without
RT to exclude possible contamination.
Standard analytical PCR reaction was performed with
GoTaq Master Mix (Promega). Each PCR tube contained the
following reagents: 5× GoTaq buffer, 0.2 μM forward primer,
0.2 μM reverse primer, 0.2 mM dNTPs, 0.5 mMMgCl2, 1.25
U GoTaq and 3,5 μl of (about 35 μg) template cDNA at a
50 μl final volume. Cycling conditions were performed with
95 °C initial denaturation step for 1 min was followed by
40 cycles consisting of 95 °C denaturation (30s), annealing
(30 s) at the appropriate temperature for each primer pair and
72 °C extension (1 min) in Gene Amp® PCR System 9700
(Applied Biosystems) thermocycler. Amplified PCR products
were visualized by 1.5 % TAE ethidium bromide-stained aga-
rose gel electrophoresis for 1 h at 100 V using UV light trans-
illuminator PC-assisted CCD camera UVB lamp (Vilber
Lourmaret, France) was used for gel documentation. Gel elec-
trophoresis of the amplification products revealed single DNA
bands with nucleotide lengths as expected for all primer pairs.
Real-time PCR
The messenger RNA (mRNA) transcription of transfected
143B and Hs888 cells and normal controls was measured.
Gene expression was analyzed by real-time PCR using the
7500 Real -Time PCR ins t rument f rom Appl ied
Biosystems™. TaqMan® primers and probes for each gene,
as well as the GAPDH reference gene, were obtained from
Applied Biosystems™. Briefly, total RNAwas extracted with
a SV Total RNA Isolation System (Promega, Madison, WI,
USA) according to the manufacturer’s instructions. The purity
and quantity of RNA was assessed by NanoDrop ND-1000
Spectrophotometer. The RNA was reverse transcribed into
Table 1 Real-time PCR results after silencing of ezrin (upper) and
PLCE (lower). (T=0) untreated; (T=24) after 24 from silencing; (T=48)
after 48 from silencing. +=mRNA present; −=mRNA absent. >=mRNA
moderately increased (not more than 30%) with respect to T0. <= mRNA
moderately decreased (not more than 30 %) with respect to T0. >> =
mRNA increased (30-75 %) with respect to T0. <<=mRNA decreased
(30–75 %) with respect to T0
Ezrin silencing
143B Hs888
T=0 T=24 h T=48H T=0 T=24 h T=48H
Ezrin + − − + − −
RhoA + > >> + < <
Rac1 + > < + << <
PLCE + < > + < >
PLCG2 + > > +/− + +
PLCB1 + < < + >> >>
PLCD4 − − − + > =
PI-PLC ε silencing
143B Hs888
T=0 T=24 h T=48H T=0 T=24 h T=48H
PLCE + − − + − −
RhoA + < < + < <
Rac1 + < < + << <<
Ezrin + < < + > =
PLCG2 + > > +/− − −
PLCB1 + < < + > >>
PLCD4 − − − + < <
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cDNA with High Capacity cDNA Reverse Transcription Kit
(Life Technologies, Foster City, CA, USA).
Amplification products were detected using gene-specific
primers and probes labeled with reporter day FAM which
yielded a predicted amplicons of 82, 84, 61, 78, 64, 93 and
62 base pairs respectively; glyceraldehyde-3-phosphate dehy-
drogenase (GAPDH) was used as an internal standard and
positive control, which yielded a predicted amplicon of 58
base pairs. Reaction mixtures for all gene expression assays
contained: 5 μl TaqMan® mastermix (2×; Applied
Biosystems™), 0,5 μl primer/probe mix specific for each an-
alyzed gene and 1 μl PCR grade water. 3,5 μl of cDNA
(35 ng) were added. PCR reaction was carried out in triplicate
on 96-well plate with 10 uL per well using 1× TaqManMaster
Mix. After 2 min incubation at 50 °C and 10 min at 95 °C, the
reaction was carried out for 40 cycles at 95 °C for 15 s and
60 °C for 1 min. At the end of the reaction, the results were
evaluated using the ABI PRISM7500 software. The Ct (Cycle
threshold) values for each set of three reactions were averaged
for calculations. The 2^-ΔΔCt method was used to calculate
relative changes in gene expression.
Western blot
Western blot analyses were conducted 24 and 48 h from trans-
fection and in unsilenced controls. Cells were washed with
cold PBS, then processed in lysis buffer (50 mM Tris-HCl,
150 mM NaCl, 2 mM EDTA, 1 % NP-40, 2 mM sodium
fluoride, 0.5 % sodium deoxycholate, and 0.1 % SDS) con-
taining protease inhibitors. 50 μg of protein was separated by
10 % sodium dodecyl sulfate–polyacrylamide gel electropho-
resis (SDS-PAGE) and transferred onto nitrocellulose mem-
branes (Invitrogen, Life Technologies, Foster City, CA, USA).
The membranes were blocked in PBS with 5 % skim milk for
1 h and incubated overnight with the primary antibodies. Fi-
nally, membranes were visualized by the addition of anti-
mouse immunoglobulin G (Jackson Immunoresearch, UK)
and anti-rabbit immunoglobulin G (Jackson Immunoresearch,
UK) enhanced chemiluminescence. Expression of β-actin
was used as an internal control to normalize results. The den-
sities of the bands on the membrane were scanned and ana-
lyzed with ImageJ software.
Immunofluorescence analysis of subcellular distribution
of target molecules
Immunofluorescence detection of RhoA and Rac1 was per-
formed on cultured transfected and non-transfected cells. Cells
were fixed with 4 % paraformaldehyde (PFA), washed and
incubated with primary antibodies (Santa Cruz Biotechnol-
ogies, CA, USA), and incubated with the Texas Red or
fluorescein-conjugated specific secondary antibody (Santa
Cruz), following the manufacturer’s indications. Cells were
counterstained with 4′,6-diamidino-2-phenylindole (DAPI)
fluorescent staining. The slides (Ibidi, Munich, Germany)
were visualized using an inverted microscope.
Statistical analysis
For in vitro studies, differences were determined either with
two-way repeated measures analysis of variance (ANOVA)
with Bonferroni’s multiple comparison test, or by student’s t
test, using Prism 5.0a software (GraphPad Software, San
Diego, CA, USA). A p value <0.05 was considered
significant.
Results
Effectiveness of silencing
Silencing of ezrin was validated by western blot, RT-PCR and
gel electrophoresis, multiliquid bioanalysis and real time PCR
analysis of mRNA transcripts compared to a non-targeting
control siRNA. Ezrin was absent or markedly reduced in
transfected cells for 48–72 interval (Fig. 1a and b).
Western blot assay showed no change in the expression of
β-actin; the expression of ezrin protein was significantly de-
creased in ezrin siRNA transfected cells compared to the cor-
responding untransfected cells and cells transfected with the
carrier metafectamine.
The mRNA expression levels in transfected cells was sig-
nificantly reduced with respect to untreated cells (p<0,001).
Real-Time PCR after ezrin silencing and statistics
In 143B cell line, the expression of RhoA increased about
10 % after 24 h and about 3 times after 48 h; the expression
of Rac1 increased 50 % after 24 h. Contemporarily PLCB1
decreased, PLCG2 slightly increased, PLCE slightly de-
creased after 24 h and slightly increased after 48 h. Statistical-
ly significant difference after 24 h from ezrin silencing was
calculated in the mRNA expression levels of RhoA
(p<0.0005) and Rac1 (p<0,005) (Figs. 1, 2 and 3).
In Hs888 cell line, the expression of RhoA decreased about
75 % after 24 h; the expression of Rac1 decreased about 95 %
after 24 h. Either molecules were reduced about 50 % after
48 h. Contemporarily PLCB1, PLCG2, and PLCD4 signifi-
cantly increased after 24 h, while PLCE slightly decreased
after 24 h and significantly increased after 48 h. Statistically
significant difference after 24 h from ezrin silencing was cal-
culated in the mRNA expression levels of RhoA (p<0.0005)
and Rac1 (p<0,005) (Figs. 1 and 2).
No changes were observed in the positive control.
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Real-Time PCR after PI-PLC ε silencing and statistics
In 143B cell line, the expression of RhoA decreased about
50 %. The expression of Rac1 decreased about 40 % after
24 h and 10% after 48 h. Ezrin decreased about 70 %, PLCB1
was reduced about 65 % after 24 h and about 15 % after 48 h,
and PLCG2 increased about 50 % after 24 h and 25 % after
48 h. Statistically significant differences in the mRNA expres-
sion levels of RhoA (p<0.00125) and Rac1 (p<0,05) was
calculated in the 24–48 h interval (Figs. 1 and 2).
In Hs888 cell line after silencing of PI-PLC ε the expres-
sion of RhoA significantly decreased about 90 % in the
Fig. 1 Upper: Istograms of Real-
time PCR for RhoA in ). (T=0)
untreated; (T=24) after 24 from
silencing; (T=48) after 48 from
silencing (a) of ezrin and (b) of
PLCE in 143B cells (dark grey)
and in Hs888 cells (pale grey).
Lower: Immunofluorescence
imaging of 143B cells for RhoA
in (T=0) untreated; (T=24) after
24 from silencing; (T=48) after
48 from silencing of ezrin and of
PLCE in 143B cells (c) and in
Hs888 cells (d). DAPI (blue) for
nuclei counterstaining, RhoA
localization and merge
DAPI/RhoA signals
Fig. 2 Upper: Istograms of Real-
time PCR for Rac1 in ). (T=0)
untreated; (T=24) after 24 from
silencing; (T=48) after 48 from
silencing (a) of ezrin and (b) of
PLCE in 143B cells (dark grey)
and in Hs888 cells (pale grey).
Lower: Immunofluorescence
imaging for Rac1 in (T=0)
untreated; (T=24) after 24 from
silencing; (T=48) after 48 from
silencing of ezrin and of PLCE in
143B cells (c) and in Hs888 cells
(d). DAPI (blue) for nuclei
counterstaining, RhoA
localization and merge
DAPI/RhoA signals
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interval 24–48 h and the expression of Rac1 significantly de-
creased about 95 % in the interval 24–48 h. Contemporarily,
ezrin increased after 24 h and was restored at the basal levels
after 48 h, PLCB1 increased two folds after 24 h and more
significantly (15 folds) increased after 48 h, PLCD4 slightly
decreased (about 15 %). Statistically significant differences in
the mRNA expression levels of RhoA (p<0.0125) and Rac1
(p<0,025) was calculated in the 24–48 h interval (Figs. 1 and 2).
No changes were observed in the positive control.
Immunofluorescence
In 143B cell line ezrin was moderately present in the cyto-
plasm, with membrane signal enhancement. PI-PLC ε was
strongly present and localized in the cytoplasm and in the
perinuclear area. Ezrin and PI-PLC ε partially co-localized
in the cytoplasm. RhoA was localized in perinuclear area
and in the cytoplasm with strong signal intensity, RAC1 was
weakly detected and localized in the perinuclear zone (Figs. 1
and 2). Ezrin and RhoA do not seem to localize in the
cytoplasm.
After Ezrin silencing, a slight reduction of PI-PLC ε stain-
ing was observed in the cytoplasm. The signal intensity of
RhoA did not apparently change, although the protein was
displaced in the nucleus (Fig. 1). Strong increase of Rac1
was observed, localized in the perinuclear area (Fig. 2).
After PLCE silencing, Ezrin, slightly decreased, moved
from the plasma membrane to the perinuclear area. Moderate
reduction of RhoA signal intensity in the cytoplasma (Fig. 1)
and marked reduction of the Rac1 perinuclear signal intensity
was detected (Fig. 2).
In Hs888 cell line ezrin was mildly present and localized in
the cytoplasm. PI-PLC ε was also weakly localized in cyto-
plasm. Ezrin and PI-PLC ε partially co-localized in the cyto-
plasm. RhoA and Rac1 were strongly localized in the
perinuclear area and cytoplasm. After Ezrin silencing, the sig-
nal intensity of RhoA was weaker, the cytoplasmic signal of
Rac1 moderately decreased. After ezrin silencing RhoA and
actin colocalized in the cytoplasm (Fig. 3). PI-PLC ε silencing
induced marked reduction of RhoA andmoderate reduction of
Rac1 in the cytoplasm. The signal intensity for ezrin slightly
decreased in the cytoplasm and a more evident perinuclear
staining was observed, with loss of membrane staining
(Figs. 1 and 2).
Discussion
The activity of ERM proteins, essential for actin assembly
(Defacque et al. 2000, 2002), largely depends on membrane
PIP2 levels (Hao et al. 2009), regulated by PI-PLC enzymes.
Both ezrin and PI-PLC enzymes recognize and bind the PIP2
on the plasma membrane, probably in a competitive manner.
Moreover, both ezrin and selected PI-PLC enzymes, such as
isoforms belonging to the PI-PLC β subfamily and PI-PLC ε,
are involved in the Ras mediated signal transduction. The
transcription of PLCE gene was affected by ezrin silencing
(Lo Vasco et al. 2014b) and transcription of ezrin was affected
by PI-PLC ε silencing (Lo Vasco et al. 2014c).
The reduction of PIP2 levels induced relocation of ezrin
within the cell (Barret et al. 2000). Expression of dominant
negative Rac1 reduced ezrin at adherens junctions. Inactiva-
tion of RhoA resulted in inhibition of ezrin relocation. Then,
RhoA might be involved upstream in the pathway, probably
masking the actin binding site (Auvinen et al. 2007) or using a
common downstream effector (Auvinen et al. 2007). Our
present results suggest that such an effector might be one or
more PI-PLC isoform.
In the present experiments, silencing both ezrin and PI-
PLC ε had distinct effects upon 143B cell line and Hs888,
probably due to the different features of the cell lines, as sug-
gested by previous reports (Lo Vasco et al. 2013a, b, c).
Perinuclear relocation of ezrin contemporarily occurred to
RhoA and Rac1 reduction. Both ezrin relocation and reduc-
tion of RhoA and Rac1 might be related to PI-PLC ε lacking.
Fig. 3 Immunofluorescence
imaging of partial co-localization
of actin and RhoA in HS888 cells:
(upper line) after ezrin silencing
and (lower line) after PI-PLC ε
silencing
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In the 143B cell line, RhoA expressionwas modified by PI-
PLC ε reduction. Ezrin silencing increased the expression of
PLCG2, RhoA, Rac1, and after 48 h of PLCE. By contrast,
decreased the expression of PLCB1 and after 24 h of PLCE.
PLCE silencing increased the expression of PLCG2, and de-
creased the expression of Vil2 (OMIM *123900), the gene
which codifies for ezrin, PLCB1, PLCD4, RHOA (OMIM
*165390) and RAC1 (OMIM *602048). The behaviour of
RhoA linearly correlates with the expression of PI-PLC ε. PI-
PLC ε decreased after 24 h from both ezrin silencing and PI-
PLC ε silencing, as well as RhoA. When, the transcription of
PI-PLC ε increased also RhoA was significantly enhanced.
Moreover, in 143B cells, RhoA was displaced in the nucleus
after ezrin silencing. The nuclear distribution of RhoA is
thought to represent a critical element (Li et al. 2001). Our data
suggest that the expression of RhoA might be affected by the
expression of PI-PLC ε. However, further studies are required
in order to investigate the level of regulation networking RhoA
and PI-PLC ε and the role in the nuclear displacement of RhoA.
PLCE silencing also induced displacement of Ezrin, according
to previous findings (Lo Vasco et al. 2014b). Rac1 was dem-
onstrated to regulate the intracellular localization of Ezrin, with
a mechanism involving RhoA and strictly related to the F-actin
binding activity (Auvinen et al. 2007). Expression of dominant
negative Rac1 modified ezrin localization.
In Hs888 PLCE silencing induced increase of ezrin and
decrease of RhoA and Rac1, while Vil2 silencing reduced
RhoA, Rac1 and PLCE. Accordingly to literature data, RhoA
co-localized with actin after ezrin silencing, as well as after PI-
PLC ε silencing, in a much less evident manner. Although
these results cannot be considered conclusive, no direct link
was substantiated for the regulation of the transcription of
those molecules. On the other hand, the expression of PI-
PLC β1 was significantly increased after either silencing ex-
periments, confirming previous data (Lo Vasco et al. 2014b,
c). The reduction of PI-PLC ε also increased PLCB1 and
decreased PLCD4. The reduction of ezrin increased PLCB1,
PLCG2, PLCD4 and decreased PLCE expression (Lo Vasco
et al. 2014c). The overall results suggest that the regulation of
PI-PLC β1, RhoA and Rac1 transcription might affect each
other in a complex, unclear manner. That suggests a possible
link between RhoA and PI-PLC β1. PI-PLC β1 was recently
demonstrated to be down regulated in some cancers and to be
involved in cell differentiation (Li et al. 2011; Lo Vasco 2010;
Lo Vasco et al. 2004, 2012, 2013b; Kaminskas et al. 2005;
Martins et al. 2014). In our present findings, decrease of ezrin,
which is thought to facilitate tumour progression, is associated
to increase ofPLCB1 transcription and of cytoplasmic PI-PLC
β1 enzyme. However, the mechanism and the ordered timing
of recruitment is not clear, as well as the relationship of ezrin,
PI-PLC enzymes and Ras GTPases. Further studies are re-
quired in order to verify the specific role of each molecule
upon the regulation of the others.
The overall present results suggestthat suppression of
the metastasis promoting Ezrin induce up-regulation of
PI-PLC β1.
RhoA and Rac1 are differently expressed after Ezrin or PI-
PLC ε silencing. The modulation of RhoA we observed in
143B cells fits with the expression of PI-PLC ε, according
to literature data. That suggested that RhoA and PI-PLC ε
participate in the same pathway, probably playing a concur-
ring role. Unfortunately, controversial literature reports indi-
cated both favouring and opposing roles to cancer progression
for PI-PLC ε (49), probably depending on the cell/tumour
type. In Hs888, the reduction of ezrin, RhoA and Rac1, sup-
posed to play a tumour facilitating role, occurs contemporarily
to increased expression of PI-PLC β1 enzyme. That suggests
that the regulation of Ezrin activity is more complex in Hs888
and might involve further PI-PLC isoforms with respect to the
143B cell line, probably due to the different origins of the two
cell lines.
Further studies, addressed to identify the crosstalk and the
ordered timing of action of Ezrin, cell line-specific PI-PLC
enzymes and RasGTPases might help to elucidate the specific
role of the molecules, opening the way to novel insights in the
progression of the disease, with special regard to metastatic
spread inputs, and, as far as one can see, to novel therapeutic
strategies.
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